Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ECE1 | P42892 | 4/20 | 0.40 |
| ▸ | PLA2G2A | P14555 | 1/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.35 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.34 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.33 |
| ▸ | ITGB3 | P05106 | 4/20 | 0.33 |
| ▸ | ITGA2B | P08514 | 3/20 | 0.33 |
| ▸ | ITGAV | P06756 | 1/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
| ▸ | HTT | P42858 | 1/20 | 0.33 |
| ▸ | NAALAD2 | Q9Y3Q0 | 1/20 | 0.32 |
| ▸ | PRMT1 | Q99873 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.31 |
| ▸ | FAAH | O00519 | 1/20 | 0.31 |
| ▸ | CNR1 | P21554 | 1/20 | 0.31 |
| ▸ | CNR2 | P34972 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29136617 | 1.00 | ECE1 (0.40) | ECE1PLA2G2AKMT2ANPSR1ADRA1A | |
| SCHEMBL786150 | 1.00 | ECE1 (0.40) | ECE1PLA2G2AKMT2ANPSR1ADRA1A | |
| SCHEMBL178169 | 1.00 | ECE1 (0.40) | ECE1PLA2G2AKMT2ANPSR1ADRA1A | |
| Water SCHEMBL158122 | 0.98 | ECE1 (0.39) | ECE1PLA2G2AKMT2ANPSR1ADRA1A | |
| Hydrochloric Acid SCHEMBL7084741 | 0.98 | ECE1 (0.39) | ECE1PLA2G2AKMT2ANPSR1ADRA1A | |
| Water SCHEMBL27080 | 0.98 | ECE1 (0.39) | ECE1PLA2G2AKMT2ANPSR1ADRA1A | |
| Hydrochloric Acid SCHEMBL5610896 | 0.98 | ECE1 (0.39) | ECE1PLA2G2AKMT2ANPSR1ADRA1A | |
| Hydrochloric Acid SCHEMBL6055023 | 0.98 | ECE1 (0.39) | ECE1PLA2G2AKMT2ANPSR1ADRA1A | |
| Water SCHEMBL502962 | 0.98 | ECE1 (0.39) | ECE1PLA2G2AKMT2ANPSR1ADRA1A | |
| Hydrochloric Acid SCHEMBL7084728 | 0.98 | ECE1 (0.39) | ECE1PLA2G2AKMT2ANPSR1ADRA1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 524 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4013834-B1 | FLUORESCENT POLYMER, FLUORESCENT PROBE AND CONJUGATION KIT FOR ADVANCED FUNCTIONAL ANALYSIS OF CELLS IN HAEMATOLOGY, IMMUNOLOGY AND MICROBIOLOGY, METHOD OF PREPARATION AND USE THEREOF | I T A INTERTACT S R O (CZ) | 2025-02-19 | — | — | EP | claimed |
| US-11827729-B2 | Method for producing polyvinylphosphonic acid copolymer | MARUZEN PETROCHEMICAL CO., LTD. (JP) | 2023-11-28 | — | — | US | claimed |
| US-20220332987-A1 | METHOD FOR APPLYING A THREADLIKE ADHESIVE BODY, AND TEMPORARY-SUPPORT-SUPPORTED THREADLIKE ADHESIVE BODY | NITTO DENKO CORPORATION (JP) | 2022-10-20 | — | — | US | claimed |
| EP-4036183-A1 | METHOD FOR BONDING THREAD-LIKE ADHESIVE BODY, AND THREAD-LIKE ADHESIVE BODY WITH PROVISIONAL SUPPORT | NITTO DENKO CORPORATION (JP) | 2022-08-03 | — | — | EP | claimed |
| EP-2459607-B1 | HYBRID COPOLYMER COMPOSITIONS FOR PERSONAL CARE APPLICATIONS | NOURYON CHEMICALS INT BV (NL) | 2021-04-14 | — | — | EP | claimed |
| US-10662151-B1 | Process for preparing DTEA HCl | AMSA, INC. (US) | 2020-05-26 | — | — | US | claimed |
| EP-3377589-B1 | METHOD FOR REDUCING THE VISCOSITY OF VISCOSIFIED FLUIDS FOR APPLICATIONS IN NATURAL GAS AND OIL FIELDS | TOUGAS OILFIELD SOLUTIONS GMBH (DE) | 2019-10-09 | — | — | EP | claimed |
| EP-3153528-B1 | WATER-ABSORBENT RESIN AND WATER-ABSORBENT RESIN PRODUCTION METHOD | SUMITOMO SEIKA CHEMICALS (JP) | 2019-07-31 | — | — | EP | claimed |
| EP-2993189-B1 | METHOD FOR PRODUCING WATER-ABSORBENT RESIN | SUMITOMO SEIKA CHEMICALS (JP) | 2018-04-04 | — | — | EP | claimed |
| EP-2938429-B1 | MICROCAPSULE PARTICLES | ENCAPSYS LLC (US) | 2018-02-28 | — | — | EP | claimed |
| EP-2159643-B1 | Toner composition and method of preparation | XEROX CORP (US) | 2017-03-29 | — | — | EP | claimed |
| EP-2616473-B1 | MIXTURES CONTAINING PHOSPHOROUS, PROCEDURES FOR THEIR PRODUCTION AND USE | CLARIANT INT LTD (CH) | 2016-11-09 | — | — | EP | claimed |
| US-8900335-B2 | CMP polishing slurry and method of polishing substrate | HITACHI CHEMICAL COMPANY, LTD. (JP) | 2014-12-02 | — | — | US | claimed |
| US-20120160771-A1 | Separation Material | GAMBRO LUNDIA AB (SE) | 2012-06-28 | — | — | US | claimed |
| WO-2026105750-A1 | HOLDER FOR CELLS, METHOD FOR HOLDING FLOATING CELLS, AND METHOD FOR RECOVERING FLOATING CELLS | 日産化学株式会社 | 2026-05-21 | — | — | WO | disclosed |
| EP-4508098-B1 | METHOD OF FORMING AN OBJECT | QUADRATIC 3D INC (US) | 2026-05-06 | — | — | EP | disclosed |
| EP-4738003-A2 | PHOTOHARDENABLE COMPOSITIONS AND METHODS OF FORMING AN OBJECT | Quadratic 3D, Inc. (US) | 2026-05-06 | — | — | EP | disclosed |
| US-20030027073-A1 | Image forming method | FUJI XEROX CO., LTD. (JP) | 2003-02-06 | — | — | US | disclosed |
| US-20030004219-A1 | Composition and uses thereof | MITSUI CHEMICALS, INC. | 2003-01-02 | — | — | US | disclosed |
| US-20020183408-A1 | Composition and uses thereof | MITSUI CHEMICALS, INC. (JP) | 2002-12-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10662151-B1 | Process for preparing DTEA HCl | CPNE4, TMT1A, QDPR | ECE1 628/4885PLA2G2A 3720/4885KMT2A 893/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.